To: herry iball who wrote (42018 ) 4/7/2000 8:53:00 PM From: myturn Respond to of 150070
MEDQ is one of my longs on the Nasdaq. Those who are still sitting on the fence; it has all the signals that is getting ready to pop. 1.Increase in daily share price over the past week from $27 to $35. 2.Increase volume over the past week from about 500,000 shares a day to about 1.5 million a day. 3.The biggest thing that caught my attention today was the new addition of some major Market Makers. Goldman Sachs, Prudential, etc. just a to name a few. Goldman Sachs and Prudential are not one of the Institutional holders. I expect a strong earnings announcement sometime soon. I also expect a major announcement. The CEO back in February stated in his conference call that MEDQ had some major announcements right around the corner. I have yet to see any major announcements since he said this in February. I also expect some kind of buy recommendation. Just My Opinion, but what do I know. LOL. Check out this info I pulled off of Yahoo and their latest filings. This company is a gold mine and safe heaven for you to stick some of your penny profits into. 1. Morgan Stanley Dean Witter holds more than 1 million shares of it.biz.yahoo.com 2.Revenue. Revenue increased 21.0% from $199.8 million for the nine months ended September 30, 1998 to $241.6 million for the comparable 1999 period. The increase resulted from increased sales to existing customers, sales to new customers and additional revenue from acquisitions. Profile from Yahoo.: Medquist Inc. converts free-form medical dictation into electronically formatted patient records that healthcare providers use in connection with patient care and for other administrative purposes. The Company provides clients with its Medical Transcription System (MTS), an integrated transcription and document management system based upon proprietary software. The Company's technical staff customizes MTS to address initial data capture, conversion of data into electronic format, editing of data and routing of electronically formatted reports to the client's host computer system. The Dictation Tracking System (DTS) enables the Company and its clients to track the status of particular patient data and transcribed reports at any point in time. Clients also use DTS as an integral management tool to monitor physician timeliness in the dictation, review and sign-off process and to evaluate the Company's on-time performance. Financial Summary MedQuist, Inc. provides electronic transcription and document management services to the healthcare industry converting free-form medical dictation into electronically formatted patient records. For the fiscal year ended 12/31/99, revenues rose 21% to $330 million. Net income totalled $40.2 million, up from $3.2 million. Revenues reflect the addition of new customers and higher sales to existing clients. Net income also reflects a $2.6 million restructuring credit vs. a $18.2 million ch